These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34881399)

  • 1. Fabrication of Stable Apigenin Nanosuspension with PEG 400 as Antisolvent for Enhancing the Solubility and Bioavailability.
    Xu R; Jiang C; Zhou L; Li B; Hu Y; Guo Y; Xiao X; Lu S
    AAPS PharmSciTech; 2021 Dec; 23(1):12. PubMed ID: 34881399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability.
    Singh MK; Pooja D; Ravuri HG; Gunukula A; Kulhari H; Sistla R
    Phytomedicine; 2018 Feb; 40():48-54. PubMed ID: 29496174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization and antitumor activity evaluation of apigenin nanoparticles by the liquid antisolvent precipitation technique.
    Wu W; Zu Y; Wang L; Wang L; Wang H; Li Y; Wu M; Zhao X; Fu Y
    Drug Deliv; 2017 Nov; 24(1):1713-1720. PubMed ID: 29115900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design.
    Kassem MAA; ElMeshad AN; Fares AR
    AAPS PharmSciTech; 2017 May; 18(4):983-996. PubMed ID: 27506564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of a nanosuspension stabilized by Soluplus® to improve bioavailability.
    Yang H; Teng F; Wang P; Tian B; Lin X; Hu X; Zhang L; Zhang K; Zhang Y; Tang X
    Int J Pharm; 2014 Dec; 477(1-2):88-95. PubMed ID: 25455766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of Nanosuspension Directly Loaded Fast-Dissolving Films for Enhanced Oral Bioavailability of Olmesartan Medoxomil: In Vitro Characterization and Pharmacokinetic Evaluation in Healthy Human Volunteers.
    Alsofany JM; Hamza MY; Abdelbary AA
    AAPS PharmSciTech; 2018 Jul; 19(5):2118-2132. PubMed ID: 29700766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies.
    Patel HP; Chaudhari PS; Gandhi PA; Desai BV; Desai DT; Dedhiya PP; Vyas BA; Maulvi FA
    Int J Pharm; 2021 May; 600():120474. PubMed ID: 33737093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality by design-based optimization of formulation and process parameters for berberine nanosuspension for enhancing its dissolution rate, bioavailability, and cardioprotective activity.
    Alsabeelah N; Kumar V
    J Food Biochem; 2022 Oct; 46(10):e14361. PubMed ID: 35929374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation and characterization of icariin nanosuspension and lyophilized powder].
    Hui-Rong XI; Hui-Ping MA; Ke-Ming C; Xiao-Shuan L
    Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(20):4902-4908. PubMed ID: 33350263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and Characterization of Stable Nanosuspension for Dissolution Rate Enhancement of Furosemide: A Quality by Design (QbD) Approach.
    Marzan AL; Tabassum R; Jahan B; Asif MH; Reza HM; Kazi M; Alshehri SM; de Matas M; Shariare MH
    Curr Drug Deliv; 2018; 15(5):672-685. PubMed ID: 29359667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
    Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R
    Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced biopharmaceutical performance of brick dust molecule nilotinib via stabilized amorphous nanosuspension using a facile acid-base neutralization approach.
    Chougule M; Sirvi A; Saini V; Kashyap M; Sangamwar AT
    Drug Deliv Transl Res; 2023 Oct; 13(10):2503-2519. PubMed ID: 37024611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, Characterization and In Vivo Assessment of Repaglinide Nanosuspension for Oral Bioavailability Improvement.
    Zawar LR; Bari SB
    Recent Pat Drug Deliv Formul; 2018; 12(3):162-169. PubMed ID: 30003863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
    Gajera BY; Shah DA; Dave RH
    Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
    Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
    Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research progress on
    Shen BD; Shen CY; Xu LX; Zhu WF; Yuan HL
    Zhongguo Zhong Yao Za Zhi; 2018 Oct; 43(19):3828-3833. PubMed ID: 30453705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and Characterization of Celecoxib Nanosuspension Using Bead Milling.
    Kim HI; Jee JP; Kim ST; Kang D; Kim YC; Kim HC; Park SY; Lee HM; Cho KH; Kim DY; Choi SU; Jang DJ
    J Nanosci Nanotechnol; 2019 Feb; 19(2):1184-1187. PubMed ID: 30360230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanosuspension-Based Repaglinide Fast-Dissolving Buccal Film for Dissolution Enhancement.
    Ghadhban HY; Ahmed KK
    AAPS PharmSciTech; 2024 Jul; 25(6):161. PubMed ID: 38992175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanosuspension development of scutellarein as an active and rapid orally absorbed precursor of its BCS class IV glycoside scutellarin.
    Yang X; Miao X; Cao F; Li S; Ai N; Chang Q; Lee SMY; Zheng Y
    J Pharm Sci; 2014 Nov; 103(11):3576-3584. PubMed ID: 25187229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of amorphous ezetimibe nanosuspensions intended for enhancement of oral bioavailability.
    Thadkala K; Nanam PK; Rambabu B; Sailu C; Aukunuru J
    Int J Pharm Investig; 2014 Jul; 4(3):131-7. PubMed ID: 25126526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.